Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schizophrenia

IF 3.6 3区医学 Q2 PHARMACOLOGY & PHARMACY

Pharmacopsychiatry Pub Date : 2022-11-01 DOI:10.1055/s-0042-1757664

M. Haaf, S. Ćurić, S. Steinmann, J. Rauh, C. Mulert, G. Leicht

引用次数: 0

查看原文本刊更多论文

精神分裂症的甘氨酸和氯胺酮模型：调节N-甲基-D-天冬氨酸受体（NMDAR）为精神分裂症谷氨酸假说提供了新的见解

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacopsychiatry 医学-精神病学

CiteScore

7.10

自引率

9.30%

发文量

审稿时长

6-12 weeks

期刊介绍： Covering advances in the fi eld of psychotropic drugs, Pharmaco psychiatry provides psychiatrists, neuroscientists and clinicians with key clinical insights and describes new avenues of research and treatment. The pharmacological and neurobiological bases of psychiatric disorders are discussed by presenting clinical and experimental research.